Prescription in first 6 months after index date in exposed cohort patients
| Medication prescribedb | COPD | Asthma | IHD | |||
|---|---|---|---|---|---|---|
| Patients, n | Who received prescriptiona in first 6 months, n (%) | Patients, n | Who received prescriptiona in first 6 months, n (%) | Patients, n | Who received prescriptiona in first 6 months, n (%) | |
| In whole cohort | 75 698 | 26 055 (34.4) | 75 698 | 26 313 (34.8) | 75 698 | 25 828 (34.1) |
| In those who received a diagnosisc | 9111 | 4810 (52.8) | 11 355 | 8080 (71.2) | 13 110 | 7360 (56.1) |
| 0–6 months | 2970 | 1969 (66.3) | 4430 | 3918 (88.4) | 4430 | 2398 (54.1) |
| >6–12 months | 685 | 390 (56.9) | 1032 | 784 (76.0) | 1115 | 744 (66.7) |
| >12–36 months | 1835 | 878 (47.8) | 2335 | 1511 (64.7) | 2562 | 1591 (62.1) |
| >36 months | 3621 | 1573 (43.4) | 3558 | 1867 (52.5) | 5003 | 2627 (52.5) |
| In those did not receive a diagnosisc | 66 587 | 21 245 (31.9) | 64 343 | 18 233 (28.3) | 62 588 | 18 468 (29.5) |
↵a Before the date of diagnosis if diagnosis occurred within first 6 months (pre-diagnosis prescription).
↵b COPD/asthma-related medications regarding COPD and asthma; and IHD-related medications regarding IHD.
↵c Diagnosis during the follow-up period. COPD = chronic obstructive pulmonary disease. IHD = ischaemic heart disease.